FCCC LOGO Faculty Publications
Simon GR
Individualizing Chemotherapy for Non-small Cell Lung Cancer (NSCLC) in the Adjuvant and Advanced Setting: Current Status and Future Directions
Current Treatment Options in Oncology. 2008 Dec;9(4-6) :300-312
PMID: ISI:000267146600007   
Back to previous list
Abstract
Treatments based on molecular determinants are likely to be increasingly explored in the future. Future challenges will include ensuring that molecular determinants are identified as novel chemotherapeutic agents are being developed, enabling rationale therapeutics. Clinical trials will then enrich patients with the molecular determinants, potentially increasing response rates and survival in a specific group of patients who express this molecular determinant. It is hoped that this patient-specific aEuro(1)individualized cocktails' will substantially improve response rates and survival.
Notes
Simon, George R. 39 SPRINGER; 233 SPRING ST, NEW YORK, NY 10013 USA 459XO